Skip to main content

Table 1 Patient characteristics

From: 68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas

Patient number

Tumor locationa

Recurrent (Yes/No)

Prior resection (Yes/No)

Prior RT (Yes/No)

Dose (Gy)

RT Modality

PET identified area not well seen on MRI

Patients with pre and post radiation 68 Ga-DOTATATE PET/CT and MRI

1

1

No

No

No

52.2

Proton

Osseous involvement

3

1

No

No

No

52.2

Proton

 

4

1

No

Yes

No

54.0

VMAT

Residual tumor post-resection

12

1

No

Yes

No

52.2

Proton

Extent of falx involvement

6

2

No

Yes

No

54.0

VMAT

Extent of falx involvement

7

2

No

No

No

54.0

Proton

Extent of falx involvement

8

2

Yes

Yes

Yes

59.4

Proton

Extent of falx involvement

9

3

Yes

Yes

No

54.0

Proton

Osseous involvement

10

4

No

No

No

50.4

Proton

Optic nerve

11

5

No

Yes

No

52.2

Proton

 

Patients with 68 Ga-DOTATATE PET/CT used for radiation planning

2

1

No

No

No

52.2

VMAT

Osseous involvement

5

1

Yes

Yes

No

52.2

VMAT

Osseous involvement

13

1

Yes

Yes

No

52.2

VMAT

Osseous involvement

14

1

No

No

No

52.2

VMAT

Extent of falx involvement

15

1

Yes

No

Yes

45.0

Proton

Additional meningioma lesion confirmed

16

1

Yes

Yes

Yes

3.0

Proton

Recurrent meningioma

17

5

No

No

No

18.0

Stereotactic Radiosurgery

Ruled out meningioma and treated as brain metastasis

18

5

No

No

No

52.2

Proton

 

19

3

Yes

Yes

No

59.4

Proton

Osseous involvement

  1. aTumor location: 1. Base of skull; 2. Falx; 3. Brain convexity; 4. Optic nerve; 5. Cerebellar pontine angle/ posterior fossa